LabCorp is Scheduled to Present at the UBS 2009 Global Life Sciences Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 11, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the UBS 2009 Global Life Sciences Conference in New York City , NY.

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 8, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch Global Healthcare Conference in London,

LabCorp Announces $250 Million Stock Repurchase Program

BURLINGTON, N.C., Aug 10, 2009 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (NYSE: LH) today announced that its Board of Directors has authorized a new stock repurchase program under which LabCorp may purchase up to an aggregate of $250 million of its Common Stock from

LabCorp Successfully Completes Acquisition of Monogram Biosciences, Inc.

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 4, 2009-- Laboratory Corporation of America® Holdings (NYSE:LH) today announced the successful completion of its acquisition of Monogram Biosciences, Inc. LabCorp acquired Monogram pursuant to a cash tender offer followed by the merger of a wholly-owned

LabCorp Is Scheduled to Present at the William Blair & Company Personalized Medicine Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 4, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that Andrew J. Conrad , Ph.D., Chief Scientist and David M. Johnston , Ph.D., Vice President and Global Head of Clinical Trials, are scheduled to speak at the

LabCorp Successfully Completes Cash Tender Offer for Outstanding Shares of Monogram Biosciences, Inc.

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 4, 2009-- Laboratory Corporation of America® Holdings (NYSE: LH) today announced the successful completion of the cash tender offer by its wholly owned subsidiary, Mastiff Acquisition Corp. , for the outstanding shares of common stock of Monogram

LabCorp Extends Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc.

Settlement of Certain Legal Proceedings Announced BURLINGTON, N.C. & SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jul. 28, 2009-- Laboratory Corporation of America ® Holdings (NYSE: LH) and Monogram Biosciences, Inc. (NASDAQ: MGRM) today announced that LabCorp is extending until 12:00 midnight,

Laboratory Corporation of America(R) Holdings Announces 2009 Second Quarter Results

Strong Revenue Growth Drives Adjusted EPS of $1.30 and Operating Cash Flow of $182.4 Million BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 23, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced results for the quarter ended June 30, 2009 .

LabCorp's Acquisition of Monogram Biosciences, Inc. Clears Antitrust Review

BURLINGTON, N.C. & SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jul. 17, 2009-- Laboratory Corporation of America ® Holdings (NYSE: LH) and Monogram Biosciences, Inc. (NASDAQ: MGRM) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act,

LabCorp Redeems All Outstanding Liquid Yield Option(TM) Notes Due 2021 and $369.1 Million Principal Amount at Maturity of Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 1, 2009-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) announced today that it has completed the previously announced redemption of all of its outstanding zero coupon subordinated Liquid Yield Option ™ Notes due 2021 ( LYONs ) and $369.1